Showing 34,857 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Coronavirus

Study Bite: HIV False Positives in People Who Had COVID-19

Editor's pick
TheBodyPro
6 March 2023
HIV treatment

Lenacapavir (Sunlenca)

About HIV
March 2023
HIV treatment

Lenacapavir

About HIV
March 2023
Viral load

Southern Alberta study assesses who is at risk for HIV viral breakthrough episodes

Editor's pick
CATIE
3 March 2023
Neurological & cognitive problems

Brain Aging in HIV Affected by Adverse Social Determinants of Health, Comorbidities

Editor's pick
Infectious Disease Advisor
3 March 2023
Access to healthcare

Gay and bisexual men in India lack vital HIV and STI information and testing rates are low

Editor's pick
Be In The Know
3 March 2023
Mpox (monkeypox)

US: Disproportionately low number of Black individuals received the mpox vaccine

Editor's pick
The Hill
3 March 2023
Coronavirus

Common HIV medication associated with improved COVID-19 outcomes

Editor's pick
Kaiser Permanente
3 March 2023
Mpox (monkeypox)

Opinion: "The UK has quietly done an incredible job of fighting mpox – but it's no thanks to ministers"

Editor's pick
The Guardian
2 March 2023
Neurological & cognitive problems

Sleep disturbances are associated with cognitive function in women living with HIV

Editor's pick
NATAP
2 March 2023
Young people

New study reveals parents' concerns about their sexual and gender minority teens using PrEP for HIV prevention

Editor's pick
Medical Xpress
2 March 2023

CROI 2023: Nuovo promettente metodo di somministrazione della PrEP sottoposto al primo studio di sicurezza per il sesso anale, mercoledì 1 marzo 2023

March 2023

КРОИ 2023: Новый многообещающий метод доконтактной профилактики (ДКП) апробируется в первом исследование безопасности его применения при анальном сексе, Среда, 01 марта 2023 г.

March 2023

CROI 2023: Novo método promissor de PrEP passa no primeiro estudo de segurança para sexo anal, Quarta-feira, 1 de março de 2023

March 2023

CROI 2023: Un prometedor nuevo método de PrEP supera el primer estudio de seguridad para el sexo anal, Miércoles, 1 de marzo de 2023

March 2023
Injectable & long-acting PrEP

CROI 2023: Islatravir implant for PrEP Video

March 2023
HIV in the arts & media

HIV Ireland to receive €25000 from Sunday Times following “grossly inaccurate” article

Editor's pick
Gay Community News
1 March 2023

CROI 2023: Une nouvelle forme de PrEP prometteuse fait l'objet de la première étude de tolérance pour les rapports sexuels avec pénétration anale, Mercredi 1er mars 2023

March 2023
Money

India: Irdai asks insurers to design covers for mental illness, HIV

Editor's pick
The Times of India
1 March 2023
Injectable & long-acting PrEP

Experimental islatravir implants protect monkeys against HIV-like virus

News
1 March 2023
PrEP programmes & uptake

Tenofovir disoproxil-based pill regains its position as first choice for PrEP in the US

News
1 March 2023

CROI 2023: Promising new PrEP method undergoes first safety study for anal sex, Wednesday 1 March 2023

March 2023
How HIV works

HIV Reservoirs Are Established Earlier Than Expected

Editor's pick
Université de Montréal
1 March 2023
Bad science & bogus treatments

No, Gammora HIV ‘cure kits’ not medically proven – stick to approved treatment

Editor's pick
Africa Check
1 March 2023